|
|
 |
|
Viewing report
|
|
|
|
Pharmacogenomics for Clinical Use and in Drug Development
TriMark Publications, June 2009, Pages: 244
Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the population based on their particular responses to a drug. The knowledge of the likely effectiveness of a drug in a patient makes the drug more reliable, and fewer drugs would have to be taken off the market due to adverse reactions in some, but not all, of the patients to whom they were administered. Additionally, reducing the occurrence of adverse effects to a drug effectually reduces the cost of patient care overall.
This publications study examines the market for diagnostic tests based on this science and the clinical measurement methods, the reagents and supplies being utilized in clinical medicine and the pharmaceutical industry. This report presents an overview of the latest information regarding emerging new products and industry trends and will not only quantify, but also, qualify the pharmacogenomic market segments as an area of research, product development and investment opportunity. Forecasts of the pharmacogenomic market and an analysis of products in the worldwide diagnostics market will provide a basis for understanding the significance of past developments and the immense possibilities of the future.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Also available
Genetics Bundle
Customers who bought this item also bought
How to Get Ahead with Pharmacogenomics
Understanding Pharmacogenomics
Impact of Pharmacogenomics on Public Healthcare Policy: Educating Patients, Payors and Healthcare Providers
The Role of Pharmacogenomics in Personalized Medicine
Developments in Pharmacogenomics (Technical Insights)
The Pharmacogenomics Outlook
Personalized Medicine: The Impact of Pharmacogenomics on Pharmaceutical R&D and Sales
Cancer Diagnostic Testing World Markets
World Pharmacogenomics — Future of Healthcare Industry 2009™
European Personalised Medicine and Pharmacogenomics Markets
Women’s Health Diagnostic Testing
Point of Care Diagnostic Testing World Markets
|
|
|
|
